
Cannara Biotech
(OTC) LOVFF
Cannara Biotech Financials at a Glance
Market Cap
$130.39M
Revenue (TTM)
$112.67M
Net Income (TTM)
$11.81M
EPS (TTM)
$0.09
P/E Ratio
14.32
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$1.32
Volume
100
Open
$1.32
Price
$1.32
Volume
100
Open
$1.32
Previous Close
$1.32
Daily Range
$1.32 - $1.32
52-Week Range
$0.77 - $1.47
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$1.32
Volume
100
Open
$1.32
Previous Close
$1.32
Daily Range
$1.32 - $1.32
52-Week Range
$0.77 - $1.47
LOVFF News
LOVFF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cannara Biotech
Industry
Personal Products
Sector
Consumer StaplesEmployees
452
CEO
Zohar Krivorot
Website
www.cannara.caHeadquarters
Saint-Laurent, QC H4N 3M9, CA
LOVFF Financials
Key Financial Metrics (TTM)
Gross Margin
39%
Operating Margin
14%
Net Income Margin
10%
Return on Equity
12%
Return on Capital
11%
Return on Assets
7%
Earnings Yield
6.98%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$130.39M
Shares Outstanding
98.78M
Volume
100
Short Interest
0.00%
Avg. Volume
5.51K
Financials (TTM)
Gross Profit
$47.22M
Operating Income
$22.20M
EBITDA
$28.18M
Operating Cash Flow
$20.01M
Capital Expenditure
$6.36M
Free Cash Flow
$13.65M
Cash & ST Invst.
$14.36M
Total Debt
$41.58M
Cannara Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$30.11M
+20.1%
Gross Profit
$11.21M
+10.1%
Gross Margin
37.23%
N/A
Market Cap
$130.39M
N/A
Market Cap/Employee
$282.85K
N/A
Employees
461
N/A
Net Income
$1.04M
-54.9%
EBITDA
$4.23M
-25.0%
Quarterly Fundamentals
Net Cash
$18.29M
+52.8%
Accounts Receivable
$15.22M
+17.7%
Inventory
$51.97M
+24.5%
Long Term Debt
$25.67M
-22.2%
Short Term Debt
$9.14M
-42.8%
Return on Assets
6.79%
N/A
Return on Invested Capital
11.14%
N/A
Free Cash Flow
$3.34M
-27.6%
Operating Cash Flow
$7.96M
+36.4%